Molecular mechanism of human uterine endometrial carcinogenesis
人子宫内膜癌变的分子机制
基本信息
- 批准号:06454468
- 负责人:
- 金额:$ 4.1万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In the process of normal cell cycle, the cooperation of factors such as tumor suppressor gene products, cyclins, and cdks is essential. Abnormalities of the cooperation of these factors may result in malignant transformation of the cell. To examine the mechanism in the development of the endometrial carcinomas, we studied the immunohistochemical reactivity of these factors in endometrial carcinoma. The normal and hyperplastic endometria adjacent to carcinoma showed positive staining for ER,PR,but negative for p53. Of 59 carcinomas, 40 showed strongly positive staining for ER and PR,but negative for p53, while the other 19 showed negative staining for ER,PR,and positive for p53. The p53 positive staining was located just in the areas with negative staining for ER and PR.In the cancer cells with weak p53 staining, Rb staining were strongly positive and cyclin E staining were weakly positive. However, in the cancer cells with strong p53 staining, Rb staining was either weak or negative, b … More ut cyclin E staining was strongly positive. These data suggest that a stepwise abnormalities of sex steroid receptors, tumor suppressors, and cyclins seems to exist. The expression of cdk4 was observed in the proliferative phase of normal endometria as well as endometrial carcinomas, but the expression was not homogenous and preferentially observed in the nucleus of the endometrial carcinomas. Low expression of p16 was observed in the proliferative phase of normal endometria and in the endometrial carcinomas. The area with high expression of p16 showed low expression of cdk4, while the area with low expression of p16 showed high expression of cdk4. No cyclin D1 expressed in normal endometria, while high expression was observed in the nucleus of the endometrial carcinomas which are highly expressed of cdk4. These data suggest that inverse expression of p16 versus cdk4 and cyclin D1 is present in the human uterine endometrial carcinomas. Taken together, , our data suggest that a stepwise abnormalities of the tumor suppressor gene products, cyclins, and cdks may correlate with the advancement of malignancy in the development of the endometrial carcinoma. Less
在正常的细胞周期过程中,肿瘤抑制基因产物、细胞周期蛋白、cdks等因子的协同作用是必不可少的。这些因素合作的异常可能导致细胞的恶性转化。为了探讨子宫内膜癌的发生机制,我们研究了这些因子在子宫内膜癌中的免疫组织化学反应性。正常及癌旁增生子宫内膜ER、PR染色阳性,p53染色阴性。59例癌中,ER、PR强阳性40例,p53阴性,ER、PR阴性19例,p53阳性。p53阳性染色仅位于ER和pr阴性染色区,p53弱染色的癌细胞Rb强阳性,cyclin E弱阳性。而在p53染色较强的癌细胞中,Rb染色呈弱或阴性,而cyclin E染色呈强阳性。这些数据表明,性类固醇受体、肿瘤抑制因子和细胞周期蛋白的逐渐异常似乎存在。cdk4在正常子宫内膜和子宫内膜癌的增殖期均有表达,但表达不均匀,在子宫内膜癌的细胞核中优先表达。p16在正常子宫内膜增殖期和子宫内膜癌中均有低表达。p16高表达区cdk4低表达,p16低表达区cdk4高表达。正常子宫内膜未见cyclin D1表达,而cdk4高表达的子宫内膜癌细胞核中cyclin D1高表达。这些数据表明p16对cdk4和细胞周期蛋白D1的逆表达存在于人子宫内膜癌中。综上所述,我们的数据表明,肿瘤抑制基因产物、细胞周期蛋白和cdks的逐步异常可能与子宫内膜癌的恶性进展有关。少
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masuzawa,H.,Bodokhon,N-H.,Nakayama,K.,Konishi,I.,Nikaido,T.,and Fujii,S.: "Failure of down-regulation of estrogen receptors and progesterone receptors after medroxyprogesterone acelate administration in endometrial hyperplasias" Cancer.74. 2321-8 (1994)
Masuzawa,H.、Bodokhon,N-H.、Nakayama,K.、Konishi,I.、Nikaido,T. 和 Fujii,S.:“子宫内膜增生症中使用醋酸甲羟孕酮后雌激素受体和孕激素受体下调失败
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Oguchi,O.,Mori,A.,Kobayashi,Y.,Horiuchi,A.,Nikaido T.,and Fujii,S.: "Prediction of histopathologic feature and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy.-Correlation between T2-weight images a
Oguchi,O.、Mori,A.、Kobayashi,Y.、Horiuchi,A.、Nikaido T. 和 Fujii,S.:“GnRH 类似物治疗前通过磁共振成像预测子宫肌瘤的组织病理学特征和增殖活性
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shuan-fang Li,Tanri Shiozawa,Kuniaki Nakayama,Toshio Nikaido and Shingo Fujii.: "Stepwise Abnormality of Sex Steroid Hormone Receptors,Tumor Suppress Gene Products p53,Rb,and Cyclin E in Human Uterine Endometrial Carcinomas." Cancer. (in press). (1996)
Shuan-fang Li、Tanri Shiozawa、Kuniaki Nakayama、Toshio Nikaido 和 Shingo Fujii.:“人类子宫内膜癌中性类固醇激素受体、肿瘤抑制基因产物 p53、Rb 和细胞周期蛋白 E 的逐步异常。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawa,S.,Yoshizawa,K.,Tokoo,M.,Imai,H.,Oguchi,H.,Kiyosawa,K.,Homma,T.,Nikaido,T.,: "Furihata,K,Inhibitory effect of a novel vitamn D3 analog,22-oxa-1,25-dihydroxyvitamin D3,n the proliferation f pancreatic cancer cell lines n vitro and in vivo." Gastroente
Kawa,S.,Yoshizawa,K.,Tokoo,M.,Imai,H.,Oguchi,H.,Kiyosawa,K.,Homma,T.,Nikaido,T.,:“Furihata,K,a的抑制作用
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masuzawa, H., Badokhon, N-H., Nakayama, K., Konishi, I., Nikaido, T., and Fujii, S.: "Failure of down-regulation of estrogen receptors and progesterone receptors after medroxyprogesterone acetate administration in endometrial hyperplasias." Cancer.74. 232
Masuzawa, H.、Badokhon, N-H.、Nakayama, K.、Konishi, I.、Nikaido, T. 和 Fujii, S.:“在子宫内膜增生症中给予醋酸甲羟孕酮后雌激素受体和孕激素受体下调失败
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NIKAIDO Toshio其他文献
NIKAIDO Toshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NIKAIDO Toshio', 18)}}的其他基金
Identification of Cervical Cancer Stem Cells and development of the new method for treatment of that cells as the target.
鉴定宫颈癌干细胞并开发以该细胞为靶标的治疗新方法。
- 批准号:
22659296 - 财政年份:2010
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The biological characteristics of amniotic membrane and it's application for regenerative medicine.
羊膜的生物学特性及其在再生医学中的应用。
- 批准号:
20390430 - 财政年份:2008
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The characteristics of amniotic membrane and it's application for regenerative medicine.
羊膜的特性及其在再生医学中的应用。
- 批准号:
16390473 - 财政年份:2004
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DEVELPOMEN TO NEW TREATMENT AND DETAILS OF THE GENETIC CHANGES UNDERLYING THE NEOPLASTIC TRANSFORMATION OF UTERINE SMOOTH MUSCLE
新疗法的发展和子宫平滑肌肿瘤转化背后的基因变化细节
- 批准号:
13470350 - 财政年份:2001
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Involvement of the abnormality of cyclins, cyclin-dependent kinases or tumor suppressor gene products in the acquisition of the malignant potential of the endometrial carcinomas.
细胞周期蛋白、细胞周期蛋白依赖性激酶或抑癌基因产物的异常参与子宫内膜癌恶性潜能的获得。
- 批准号:
09470355 - 财政年份:1997
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Probing intratumor heterogeneity and elucidating developmental mechanisms based on cancer-associated genetic mutations in ovarian endometrial carcinoma
探讨卵巢子宫内膜癌肿瘤内异质性并阐明基于癌症相关基因突变的发育机制
- 批准号:
23K08857 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyses of carcinogenesis in dedifferentiated endometrial carcinoma by using organoid and whole genome sequencing.
使用类器官和全基因组测序分析去分化子宫内膜癌的致癌作用。
- 批准号:
21K09472 - 财政年份:2021
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of trans-differentiation origin signals and their application to fertility-preservation therapy in young endometrial carcinoma
转分化起始信号的鉴定及其在年轻子宫内膜癌生育力保存治疗中的应用
- 批准号:
21K20781 - 财政年份:2021
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Artificial Intelligence for Precision Medicine in Endometrial Carcinoma
子宫内膜癌精准医疗的人工智能
- 批准号:
553089-2020 - 财政年份:2020
- 资助金额:
$ 4.1万 - 项目类别:
University Undergraduate Student Research Awards
Repurposing antiretroviral drugs for endometrial carcinoma with LINE1 expression
抗逆转录病毒药物的再利用治疗具有 LINE1 表达的子宫内膜癌
- 批准号:
20K18230 - 财政年份:2020
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Comparative analysis of endometrial carcinoma and carcinosarcoma to identify prognostic factors.
子宫内膜癌和癌肉瘤的比较分析以确定预后因素。
- 批准号:
19K16565 - 财政年份:2019
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of the significance of PPP2R1A mutation in endometrial carcinoma
PPP2R1A突变在子宫内膜癌中的意义研究
- 批准号:
18K09254 - 财政年份:2018
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel anti-cancer drugs targeting cyclin A for endometrial carcinoma.
开发针对子宫内膜癌的针对细胞周期蛋白A的新型抗癌药物。
- 批准号:
16H05471 - 财政年份:2016
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Linking Inactivating Mutations in Chromatin Remodeling Complex Subunits to Aggressive Dedifferentiated Endometrial Carcinoma
染色质重塑复合体亚基失活突变与侵袭性去分化子宫内膜癌的联系
- 批准号:
365454 - 财政年份:2016
- 资助金额:
$ 4.1万 - 项目类别:
Studentship Programs
Analysis of relation between myometrial invasion and local immunereaction in endometrial carcinoma.
子宫内膜癌肌层浸润与局部免疫反应关系分析
- 批准号:
15K10698 - 财政年份:2015
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




